Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02409342 |
|---|---|
| Brief Title: | A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] |
| First Submitted : | April 1, 2015 |
| First Submitted that Met QC Criteria : | April 1, 2015 |
| First Posted : | April 6, 2015 (Estimate) |
| Results First Submitted : | January 26, 2021 |
| Results First Submitted that Met QC Criteria : | January 26, 2021 |
| Results First Posted : | February 18, 2021 |
| Last Update Submitted that Met QC Criteria : | February 17, 2023 |
| Last Update Posted : | March 15, 2023 |